Navigation Links
AdvaMed Supports Comprehensive Tax Reform Repeal of the Medical Device Tax Important First Step
Date:7/9/2013

WASHINGTON, July 8, 2013 /PRNewswire-USNewswire/ -- Stephen J. Ubl, president and CEO of the Advanced Medical Technology Association (AdvaMed), released the following statement in response to tax-writing committee Chairmen Camp and Baucus as they begin their nationwide listening tour in favor of a simpler, fairer U.S. tax code: 

"AdvaMed commends the efforts of Ways and Means Committee Chairman Dave Camp (R-MI) and Senate Finance Committee Chairman Max Baucus (D-MT) to advance comprehensive U.S. tax reform to improve America's competitiveness and rebuild our nation's economic future. We look forward to working with them as they develop their legislation.

"As they begin their Tax Reform Tour in the Minneapolis-St. Paul, Minnesota area, it is important to note the medical technology industry supports over 35,000 jobs in the state and more than two million jobs nationally. In the context of reforming the tax code to make U.S. business more competitive, repealing the medical device excise tax that went into effect in January is a critical first step to protecting these jobs and ensuring a level playing field for Minnesota and the rest of the U.S. in the global economy.

"America's current corporate tax structure is a key factor contributing to the decline of the competitiveness of the American medical technology industry. U.S. corporate tax rates are the highest in the world. The U.S. has failed to match competitor nations in positive tax incentives to attract knowledge-based, high-value manufacturing industries like medical technology. The U.S. tax code provides few incentives to invest in the pre-profit start-up companies that are the backbone of the innovation system.

"The device tax makes an already uncompetitive tax system for the medical technology industry far less competitive and threatens our industry's continued world leadership. It raises the total tax burden for our industry by a whopping 29% – resulting in fewer job opportunities, lower R&D investment to fuel tomorrow's treatments and cures, and/or higher health care costs.

"Legislative measures to repeal the device tax passed the House last summer and the Senate in March with overwhelming bipartisan majorities. Congress and the President must act now to finish the job and repeal it."

AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit www.advamed.org.


'/>"/>
SOURCE AdvaMed
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. AdvaMed & BioOhio Discuss MedTech Impact on Ohios Economy, Job Creation
2. AdvaMed Commends House Progress on Repealing Medical Device Tax
3. Countdown Begins For AdvaMed 2012: The Medtech Conference
4. AdvaMed Launches MVP Mentoring Portal for Veterans
5. AdvaMed Opposes Puerto Rico Medical Device Tax Increase
6. Pharmaceutics International, Inc. (Pii) Supports University Pharmaceutical Technology Education and Research
7. Data Presented at the American Psychiatric Association Annual Meeting Supports Gender-Specific Dosing of Intermezzo® (zolpidem tartrate) Sublingual Tablets CIV
8. U.S. Government Supports Phase 3 Study of Bavarian Nordics Smallpox Vaccine
9. Frost & Sullivan: Expanding Sample Prep Market Supports Growth Trends in Molecular Diagnostics Markets
10. New Legislation To Make USPSTF More Transparent: Prostate Cancer Roundtable Supports Reform
11. Ventana Supports World Patient Safety Day, July 25
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... 20, 2017 Research and Markets has announced ... Driven by Rapidly Expanding Injectables Market and Increasing Usage of Complex ... ... technologies will rise from USD 20 Billion in 2015 to around ... Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market and ...
(Date:4/20/2017)... -- Research and Markets has announced the addition ... Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and ... ... valued at US$ 7,167.6 Mn in 2015, and is expected ... CAGR of 5.6% from 2016 to 2024. ...
(Date:4/19/2017)... , April 19, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE ... Bloom Burton & Co. Healthcare Investor Conference 2017 at the Sheraton ... Edward Wright , Chief Executive Officer of the Company is scheduled ... CFO, Richard Bear and the Chairman of the Board, ... ...
Breaking Medicine Technology:
(Date:4/24/2017)... ... April 24, 2017 , ... symplrTM, a leading provider ... announced that Kyle Allain has joined the company as Vice President and General ... including provider, payor and managed care solutions. , A seasoned executive with ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... are expected to be diagnosed globally; approximately 25,000 of them will be malignant.(1) ... greater use of this type of healthcare model in the diagnosis and treatment ...
(Date:4/24/2017)... ... April 24, 2017 , ... Rod Burkett, CEO of Gardant Management Solutions, was ... has been at the forefront of Gardant since it was founded in 1999. His ... the opening of more than 40 new senior living communities. With his leadership, Gardant ...
(Date:4/24/2017)... CA (PRWEB) , ... April 24, 2017 , ... As ... is worth a thousand words. The good news for single women is that she ... Attraction," which is available on April 25th. Joan's insight, personal experiences and sparkling sense ...
(Date:4/24/2017)... ... April 24, 2017 , ... Labs often perform the same ... lab operators and management to assess these processes with a critical eye—particularly in ... actions. , Created with the help of both internal and external process ...
Breaking Medicine News(10 mins):